EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

FGF14 GAA Intronic Expansion in Unsolved Adult‐Onset Ataxia in the Care4Rare Canada Consortium

Alexanne Cuillerier iD, Giulia F Del Gobbo, Layla Mackay, Erika Wall, Madeline Couse, Laura M McDonell, Mireille Cloutier, Matt C Danzi, Jodi Warman-Chardon, Pierre R Bourque, Oksana Suchowersky, Alan Mears und 9 weitere

Annals of Clinical and Translational Neurology · 2025

DOI: 10.1002/acn3.70016 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of Clinical and Translational Neurology, 2025. Verfasst von Alexanne Cuillerier und 20 weiteren Autor:innen. Beteiligte Einrichtung: Children's Hospital of Eastern Ontario Research Institute, Ottawa, Ontario, Canada. Hauptthemen laut MEDLINE: Fibroblast Growth Factors, Spinocerebellar Ataxias, Trinucleotide Repeat Expansion. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CIHR Foundation, Ontario Genomics Institute, Canada Research Chairs.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Objectives Spinocerebellar ataxias (SCA) represent a clinically and genetically heterogeneous group of progressive neurodegenerative diseases with prominent cerebellar atrophy. Recently, a novel pathogenic repeat expansion in intron 1 of FGF14 was identified, causing adult‐onset SCA (SCA27B). We aimed to determine the proportion of our unsolved adult‐onset ataxia cohort harboring this expansion using several technologies, and to characterize the phenotypic presentation within our population.

Methods

Individuals presenting with adult‐onset ataxia (> 30 years old) and negative previous genetic testing were selected from the Care4Rare patient repository. Affected individuals were from all ethnicities, and 90% had a family history suggestive of dominant ataxia, representing 19 of the 23 families included. We used multiple tools (PCR, long‐read genome sequencing and optical genome mapping (OGM)) to identify the pathogenic GAA repeat in FGF14 .

Results

Of the 23 families included in this study, 65.2% harbored a pathogenic GAA expansion in FGF14 . Individuals of French‐Canadian descent (FC) represented most of our cohort and had a 64.7% diagnostic yield. Affected individuals presented with gaze‐evoked nystagmus, gait ataxia, cerebellar dysarthria, and early episodic features. The GAA expansion in FGF14 was visible by OGM in all individuals tested.

Interpretation

Our diagnostic yield demonstrates this expansion may be the most common cause of adult‐onset SCA in dominant families of FC ancestry. Our FC participants have a phenotype distinct from previously published FC patients, with gaze‐evoked nystagmus being the most common eye anomaly. From a diagnostic standpoint, the pathogenic GAA repeat can be identified by OGM, but additional tests are required to complement the interpretation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fibroblast Growth FactorsSpinocerebellar AtaxiasTrinucleotide Repeat ExpansionHumansMaleFemaleAdultMiddle AgedCanadaAge of OnsetIntronsAgedCohort Studies

Substanzen

Fibroblast Growth Factorsfibroblast growth factor 14

Autor:innen und Institutionen

  • Children's Hospital of Eastern Ontario Research Institute, Ottawa, Ontario, Canada.
  • University of Ottawa, Ottawa, Ontario, Canada.
  • Centre for Computational Medicine, the Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.
  • Department of Genetics, Children's Hospital of Eastern Ontario, Ottawa, Ontario, Canada.
  • Dr. John T. Macdonald Foundation Department of Human Genetics and John P. Hussman Institute for Human Genomics, University of Miami Miller School of Medicine, Miami, Florida, USA.
  • Department of Medicine, Neurology, The Ottawa Hospital, Ottawa, Ontario, Canada.

ORCID-Profile: Alexanne Cuillerier, David Dyment

Förderung

  • CIHR Foundation
  • Ontario Genomics Institute
  • Canada Research Chairs
  • Children's Hospital of Eastern Ontario Foundation
  • CHEO Research Institute
  • Genome Canada
  • CIHR
  • Canadian Institutes of Health Research

Zitieren

APA

Cuillerier, A., Del Gobbo, G. F., Mackay, L., Wall, E., Couse, M., McDonell, L. M., Cloutier, M., Danzi, M. C., Warman-Chardon, J., Bourque, P. R., Suchowersky, O., Mears, A., Seldenthuis, L., Mears, W., Larrigan, L., White-Brown, A., Pfeffer, G., Bulman, D. E., Dyment, D., …, & Boycott, K. M. (2025). FGF14 GAA Intronic Expansion in Unsolved Adult‐Onset Ataxia in the Care4Rare Canada Consortium. Annals of Clinical and Translational Neurology. https://doi.org/10.1002/acn3.70016

Vancouver

Cuillerier A, Del Gobbo GF, Mackay L, Wall E, Couse M, McDonell LM, et al. FGF14 GAA Intronic Expansion in Unsolved Adult‐Onset Ataxia in the Care4Rare Canada Consortium. Annals of Clinical and Translational Neurology. 2025. doi:10.1002/acn3.70016

BibTeX
@article{Cuillerier2025,
  author = {Cuillerier, Alexanne and Del Gobbo, Giulia F and Mackay, Layla and Wall, Erika and Couse, Madeline and McDonell, Laura M and Cloutier, Mireille and Danzi, Matt C and Warman-Chardon, Jodi and Bourque, Pierre R and Suchowersky, Oksana and Mears, Alan and Seldenthuis, Luke and Mears, Wendy and Larrigan, Laura and White-Brown, Alexandre and Pfeffer, Gerald and Bulman, Dennis E and Dyment, David and Care4Rare Canada Consortium, Care4Rare Canada Consortium and Boycott, Kym M},
  title = {FGF14 GAA Intronic Expansion in Unsolved Adult‐Onset Ataxia in the Care4Rare Canada Consortium},
  journal = {Annals of Clinical and Translational Neurology},
  year = {2025},
  doi = {10.1002/acn3.70016}
}
Kostenlos starten →